N/A N=32 Randomized Treatment

Elderly Demented Patients: Aromatherapy Complementary to Psychopharmacotherapy Psychological Disorders and BPSD Behavior

BPSD (Behavioral and Psycological Symptoms of Dementia)

Bottom Line

View on ClinicalTrials.gov: NCT03662360 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Sep 2021

Primary outcome: Primary: Role of Essential Oil Therapy in Environmental Diffusion as a Complement of Psychotropic Drugs in the Management of Psychological and Behavioral Disorders (BPSD) — 21.81; 25.93; 32.87; 16.5 score on a scale — p=<0.001

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: essential oils (Other)
Age: Older Adult · 70+ yrs
Sex: All
Sponsor: Clinica Luganese Moncucco
Primary completion: Jun 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Role of Essential Oil Therapy in Environmental Diffusion as a Complement of Psychotropic Drugs in the Management of Psychological and Behavioral Disorders (BPSD)	21.81; 25.93; 32.87; 16.5; 20.00; 7.25	<0.001 sig
SECONDARY Role of Essential Oil Therapy in Environmental Diffusion in Professional Caregiver Distress Linked to BPSD	4.19; 5.64; 1.60; 4.13; 9.63; 11.64	<0.01 sig

Summary

Behavioral and psycological symptoms of dementia, (BPSD) are one of the major problem for families, doctors and for patients the same. To reduce the side effects of the standard treatments, is important to find an alternative methods of treatment, eg the aromatherapy. There is an incresing in scientific evidence the its use in dementia behavior related.

Eligibility Criteria

Inclusion Criteria

patients admitted to the acute geriatric ward;
patients with a known diagnosis of dementia associated with BPSD or diagnosis performed during hospitalization.

Exclusion Criteria

patients with alcohol-based dementia;
patients with Mild Cognitive Impairment (MCI) - section 4 -;
patients with language barrier;
patients already being treated with aromatherapy.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03662360). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.